| Literature DB >> 35976909 |
Anaïs Cazals1,2, Andrea Rau1,3, Jordi Estellé1, Nicolas Bruneau1, Jean-Luc Coville1, Pierrette Menanteau4, Marie-Noëlle Rossignol1, Deborah Jardet1, Claudia Bevilacqua1, Bertrand Bed'Hom1, Philippe Velge4, Fanny Calenge1.
Abstract
Managing Salmonella enterica Enteritidis (SE) carriage in chicken is necessary to ensure human food safety and enhance the economic, social and environmental sustainability of chicken breeding. Salmonella can contaminate poultry products, causing human foodborne disease and economic losses for farmers. Both genetic selection for a decreased carriage and gut microbiota modulation strategies could reduce Salmonella propagation in farms. Two-hundred and twenty animals from the White Leghorn inbred lines N and 61 were raised together on floor, infected by SE at 7 days of age, transferred into isolators to prevent oro-fecal recontamination and euthanized at 12 days post-infection. Caecal content DNA was used to measure individual Salmonella counts (ISC) by droplet digital PCR. A RNA sequencing approach was used to measure gene expression levels in caecal tonsils after infection of 48 chicks with low or high ISC. The analysis between lines identified 7516 differentially expressed genes (DEGs) corresponding to 62 enriched Gene Ontology (GO) Biological Processes (BP) terms. A comparison between low and high carriers allowed us to identify 97 DEGs and 23 enriched GO BP terms within line 61, and 1034 DEGs and 288 enriched GO BP terms within line N. Among these genes, we identified several candidate genes based on their putative functions, including FUT2 or MUC4, which could be involved in the control of SE infection, maybe through interactions with commensal bacteria. Altogether, we were able to identify several genes and pathways associated with differences in SE carriage level. These results are discussed in relation to individual caecal microbiota compositions, obtained for the same animals in a previous study, which may interact with host gene expression levels for the control of the caecal SE load.Entities:
Mesh:
Year: 2022 PMID: 35976909 PMCID: PMC9384989 DOI: 10.1371/journal.pone.0270012
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Summary of the results of comparisons between lines and between low and high carrier classes within lines according to the experiment.
Mean (red points) and standard deviation (SD; red bars) of the Salmonella Enteritidis abundance at 12 dpi in caecal contents (log10/g of caceal contents) of chicken groups infected with SE according to the line and experiment. Difference in mean between low and high carriers according to the line and experiment and t-test p-value. Difference in mean between lines and t-test p-value. Results of the DEG and BP GO term enrichment analyses. Results of the 16S analysis from the study [17].
Fig 2Principal component analysis of the gene expression in caecal tonsils in all samples.
The first principal component contains 29% of the variance and may be attributed to the line effect and the second principal component contains 25% of the variance and may be attributed to the sex effect.
Fig 3Principal component analysis of the gene expression in caecal tonsils from experiment 1 in each line.
(A) Principal component analysis (PCA) of the gene expression in caecal tonsils within line 61 in experiment 1. (B) PCA of the gene expression in caecal tonsils within line N in experiment 1.
Fig 4Venn diagram.
Differentially expressed genes identified by comparing different groups of animals: (A) L6L1/L6H1 and LNL1/LNH1 (low vs high carriers of lines 61 and N, respectively, in experiment 1), (B) L6L1/L6H1 and LN/L6 (low vs high carriers of line 61 in experiment 1, and line N vs line 61), and (C) LNL1/LNH1 and LN/L6 (low vs high carriers of line N in experiment 1, and line N vs line 61).
Common differentially expressed genes downregulated between LN/L6 analysis and L6L1/L6H1 analysis (potentially associated with resistance to Salmonella).
| Between LN/L6 | Between L6L1/L6H1 | |||||
|---|---|---|---|---|---|---|
| symbol | Description | id | LFC | padj | LFC | padj |
| FUT2 | fucosyltransferase 2 | ENSGALG00000001806 | 1.28 | 3.30e-03 | 1.11 | 0.05 |
| DMXL1 | Dmx like 1 | ENSGALG00000002227 | 0.23 | 0.02 | 0.47 | 0.05 |
| CEMIP | cell migration inducing hyaluronan binding protein | ENSGALG00000006413 | 0.52 | 6.03e-03 | 0.85 | 5.81e-04 |
| NOS2 | nitric oxide synthase 2 | ENSGALG00000038096 | 0.46 | 7.17e-03 | 0.76 | 9.53e-03 |
Common differentially expressed genes upregulated between LN/L6 analysis and L6L1/L6H1 analysis (potentially associated with susceptibility to Salmonella).
| Between LN/L6 | Between L6L1/L6H1 | |||||
|---|---|---|---|---|---|---|
| symbol | Description | id | LFC | padj | LFC | Padj |
| CYP4B7 | cytochrome P450, family 4, subfamily B, polypeptide 7 | ENSGALG00000010469 | -1.12 | 0.03 | -2.51 | 5.73e-04 |
| CYP2D6 | cytochrome P450 family 2 subfamily D member 6 | ENSGALG00000011894 | -0.66 | 1.37e-05 | -0.83 | 0.05 |
| CYP2AC1 | cytochrome P450, family 2, subfamily AC, polypeptide 1 | ENSGALG00000016690 | -1.49 | 0.01 | -2.91 | 9.71e-04 |
| PLEKHS1 | pleckstrin homology domain containing S1 | ENSGALG00000020679 | -0.64 | 0.01 | -0.91 | 0.02 |
| RPS6KB2 | ribosomal protein S6 kinase B2 | ENSGALG00000031629 | -0.17 | 0.04 | -0.38 | 0.04 |
Common differentially expressed genes downregulated between LN/L6 analysis and LNL1/LNH1 analysis (potentially associated with resistance to Salmonella).
| Between LN/L6 | Between L6L1/L6H1 | |||||
|---|---|---|---|---|---|---|
| symbol | Description | id | LFC | padj | LFC | padj |
| SPDEF | SAM pointed domain containing ETS transcription factor | ENSGALG00000002792 | 0.54 | 0.01 | 0.99 | 0.03 |
| FNDC5 | fibronectin type III domain containing 5 | ENSGALG00000003567 | 0.48 | 0.01 | 0.71 | 0.04 |
| CPD | carboxypeptidase D | ENSGALG00000004295 | 0.21 | 0.01 | 0.44 | 0.04 |
| RBM41 | RNA binding motif protein 41 | ENSGALG00000004832 | 0.23 | 4.51e-03 | 0.31 | 0.04 |
| S100B | S100 calcium binding protein B | ENSGALG00000006217 | 3.80 | 4.59e-65 | 1.01 | 8.66e-03 |
| TRPM5 | transient receptor potential cation channel, subfamily M, member 5 | ENSGALG00000006521 | 0.75 | 1.72e-03 | 0.87 | 0.02 |
| XKRX | XK related, X-linked | ENSGALG00000006637 | 0.41 | 1.87e-03 | 0.70 | 0.01 |
| BCAS1 | breast carcinoma amplified sequence 1 | ENSGALG00000007796 | 0.43 | 3.63e-03 | 0.60 | 0.02 |
| - | Uncharacterized | ENSGALG00000008309 | 1.16 | 5.10e-14 | 0.59 | 0.05 |
| TCERG1L | transcription elongation regulator 1 like | ENSGALG00000010470 | 0.97 | 1.06e-14 | 0.41 | 0.04 |
| TTC39A | tetratricopeptide repeat domain 39A | ENSGALG00000010540 | 0.41 | 0.02 | 0.67 | 0.02 |
| RAB3B | RAB3B, member RAS oncogene family | ENSGALG00000010567 | 0.51 | 2.27e-03 | 0.80 | 0.04 |
| SIRT5 | sirtuin 5 | ENSGALG00000012692 | 0.59 | 9.80e-20 | 0.41 | 0.02 |
| SLC22A23 | solute carrier family 22 member 23 | ENSGALG00000012816 | 0.28 | 0.01 | 0.43 | 0.02 |
| UROS | uroporphyrinogen III synthase | ENSGALG00000013688 | 0.14 | 8.61e-03 | 0.31 | 5.64e-03 |
| ENDOUL | endonuclease, polyU-specific-like | ENSGALG00000014126 | 0.17 | 0.04 | 0.35 | 0.03 |
| MOGAT2 | monoacylglycerol O-acyltransferase 2 | ENSGALG00000014170 | 0.48 | 1.42e-03 | 0.76 | 0.02 |
| SIDT1 | SID1 transmembrane family member 1 | ENSGALG00000014812 | 0.41 | 0.02 | 0.75 | 0.02 |
| GLDC | glycine decarboxylase | ENSGALG00000015053 | 1.44 | 1.e-12 | 0.66 | 0.01 |
| SLC37A1 | solute carrier family 37 member 1 | ENSGALG00000016185 | 0.32 | 0.01 | 0.41 | 0.02 |
| SH3YL1 | SH3 and SYLF domain containing 1 | ENSGALG00000016362 | 0.26 | 0.04 | 0.60 | 0.02 |
| LOC427778 | ectonucleoside triphosphate diphosphohydrolase 1 | ENSGALG00000021274 | 0.34 | 0.02 | 0.62 | 0.04 |
| MIR458 | gga-mir-458a | ENSGALG00000021908 | 1.02 | 1.30e-10 | 0.61 | 0.03 |
| HOXA4 | homeobox A4 | ENSGALG00000022622 | 0.26 | 0.01 | 0.48 | 0.03 |
| ST3GAL4 | chromosome 20 open reading frame 173 | ENSGALG00000029747 | 4.86 | 0.01 | 0.66 | 1.68e-03 |
| PAK6 | p21 activated kinase 6 | ENSGALG00000034605 | 0.34 | 0.04 | 0.78 | 0.02 |
| AOC1 | amine oxidase, copper containing 1 | ENSGALG00000036190 | 0.73 | 0.03 | 1.07 | 0.05 |
| CFAP43 | cilia and flagella associated protein 43 | ENSGALG00000036896 | 0.77 | 3.68e-08 | 0.46 | 0.04 |
| ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 | ENSGALG00000037587 | 1.51 | 3.79e-14 | 1.01 | 0.02 |
| MYRF | chromosome 5 open reading frame, human C11orf9 | ENSGALG00000041253 | 0.38 | 1.30e-03 | 0.56 | 0.04 |
| BF2 | Major histocompatibility complex class I antigen BF2 | ENSGALG00000041380 | 0.89 | 2.16e-14 | 0.32 | 0.03 |
| FAM8A1 | family with sequence similarity 8 member A1 | ENSGALG00000042858 | 0.13 | 0.04 | 0.30 | 0.02 |
| GJC3 | gap junction gamma-1 protein-like | ENSGALG00000042929 | 0.49 | 0.03 | 0.93 | 0.01 |
| SYT7 | synaptotagmin VII | ENSGALG00000043139 | 0.48 | 4.25e-04 | 0.63 | 0.04 |
| - | Uncharacterized | ENSGALG00000043598 | 0.47 | 3.49e-05 | 0.53 | 0.01 |
| RAPGEF3 | Rap guanine nucleotide exchange factor 3 | ENSGALG00000043775 | 0.65 | 4.05e-04 | 0.70 | 0.04 |
| - | Uncharacterized | ENSGALG00000046455 | 2.49 | 1.62e-44 | 0.74 | 0.04 |
| KLF1 | Kruppel-like factor 1 (erythroid) | ENSGALG00000047208 | 0.61 | 6.69e-04 | 0.85 | 0.04 |
| MUC4 | mucin 4, cell surface associated | ENSGALG00000048048 | 2.40 | 5.84e-14 | 1.45 | 1.52e-04 |
| LRRC66 | leucine rich repeat containing 66 | ENSGALG00000048601 | 0.38 | 5.60e-03 | 0.67 | 0.02 |
| CLDN7 | claudin 7 | ENSGALG00000049326 | 1.27 | 4.86e-08 | 1.02 | 0.02 |
| - | Uncharacterized | ENSGALG00000053586 | 2.20 | 3.38e-27 | 0.92 | 0.02 |
| GZF1 | GDNF inducible zinc finger protein 1 | ENSGALG00000053659 | 0.47 | 8.90e-07 | 0.44 | 0.05 |
| - | Uncharacterized | ENSGALG00000054057 | 0.17 | 0.03 | 0.36 | 0.03 |
Common differentially expressed genes upregulated between LN/L6 analysis and LNL1/LNH1 analysis (potentially associated with susceptibility to Salmonella).
| Between LN/L6 | Between L6L1/L6H1 | |||||
|---|---|---|---|---|---|---|
| symbol | Description | id | LFC | padj | LFC | padj |
| TGM3 | transglutaminase 3 | ENSGALG00000004804 | -1.43 | 8.55e-04 | -0.94 | 0.04 |
| LECT2 | leukocyte cell derived chemotaxin 2 | ENSGALG00000006323 | -2.48 | 5.47e-08 | -0.91 | 0.04 |
| JAKMIP1 | janus kinase and microtubule interacting protein 1 | ENSGALG00000015528 | -0.30 | 0.04 | -0.36 | 0.03 |
| DEFB4A | defensin beta 4A | ENSGALG00000016669 | -2.72 | 2.31e-07 | -1.29 | 0.02 |
| MTMR2 | myotubularin related protein 2 | ENSGALG00000017200 | -0.20 | 4.51e-06 | -0.21 | 0.02 |
| MMP27 | matrix metallopeptidase 27 | ENSGALG00000019060 | -0.54 | 1.23e-03 | -0.48 | 0.03 |
| CHST9 | carbohydrate sulfotransferase 9 | ENSGALG00000019489 | -1.09 | 1.49e-05 | -1.16 | 0.04 |
| SERTAD4 | SERTA domain containing 4 | ENSGALG00000026359 | -0.27 | 0.05 | -0.57 | 3.22e-03 |
| - | Uncharacterized | ENSGALG00000030245 | -0.38 | 0.04 | -1.41 | 5.34e-03 |
| - | T-cell-interacting, activating receptor on myeloid cells protein 1-like | ENSGALG00000033375 | -0.91 | 7.37e-04 | -1.33 | 0.04 |
| FKBP5 | FK506 binding protein 5 | ENSGALG00000042148 | -0.44 | 2.10e-04 | -0.36 | 0.04 |
| EPX | eosinophil peroxidase | ENSGALG00000043254 | -0.47 | 0.02 | -0.64 | 0.03 |
| SHLD1 | shieldin complex subunit 1 | ENSGALG00000049137 | -0.32 | 2.25e-03 | -0.56 | 0.04 |
| - | Uncharacterized | ENSGALG00000050793 | -0.66 | 1.11e-03 | -0.75 | 0.04 |
| - | uncharacterized LOC107049467 | ENSGALG00000052009 | -1.61 | 1.67e-04 | -2.99 | 0.04 |
BP GO terms shared between LN/L6 and L6L1/L6H1 analyses.
| GO.ID | Term |
|---|---|
| GO:0009607 | response to biotic stimulus |
| GO:0043207 | response to external biotic stimulus |
| GO:0051707 | response to other organism |
BP GO term shared between LN/L6 and LNL1/LNH1 analyses.
| GO.ID | Term |
|---|---|
| GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0003416 | endochondral bone growth |
| GO:0003417 | growth plate cartilage development |
| GO:0003418 | growth plate cartilage chondrocyte differentiation |
| GO:0006644 | phospholipid metabolic process |
| GO:0030835 | negative regulation of actin filament depolymerization |
| GO:0030837 | negative regulation of actin filament polymerization |
| GO:0032272 | negative regulation of protein polymerization |
| GO:0043242 | negative regulation of protein complex disassembly |
| GO:0043244 | regulation of protein complex disassembly |
| GO:0051494 | negative regulation of cytoskeleton organization |
| GO:0051693 | actin filament capping |
| GO:0098868 | bone growth |
| GO:1901880 | negative regulation of protein depolymerization |
BP GO term shared between L6L1/L6H1 and LNL1/LNH1 analyses.
| GO.ID | Term |
|---|---|
| GO:0003008 | system process |
| GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0042592 | homeostatic process |
| GO:0065008 | regulation of biological quality |